Home › Therapeutic areas › Hematology › Cold Agglutinin Disease

Cold Agglutinin Disease (1 companies)

Companies with an active program in Cold Agglutinin Disease.

Ticker Company Therapeutic areas Programs Lead stage Mkt cap Programs
ANNX Annexon HematologyNeurology+2 Rare 1 Phase 3 $796M 6